Enoxaparin vs unfractionated heparin in acute coronary syndrome.
Publication
, Journal Article
Kanna, B; Sharma, P
Published in: JAMA
October 27, 2004
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
October 27, 2004
Volume
292
Issue
16
Start / End Page
1952
Location
United States
Related Subject Headings
- Myocardial Infarction
- Humans
- Heparin
- General & Internal Medicine
- Fibrinolytic Agents
- Enoxaparin
- Angina Pectoris
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kanna, B., & Sharma, P. (2004). Enoxaparin vs unfractionated heparin in acute coronary syndrome. JAMA, 292(16), 1952. https://doi.org/10.1001/jama.292.16.1952-b
Kanna, Balavenkatesh, and Puneeta Sharma. “Enoxaparin vs unfractionated heparin in acute coronary syndrome.” JAMA 292, no. 16 (October 27, 2004): 1952. https://doi.org/10.1001/jama.292.16.1952-b.
Kanna B, Sharma P. Enoxaparin vs unfractionated heparin in acute coronary syndrome. JAMA. 2004 Oct 27;292(16):1952.
Kanna, Balavenkatesh, and Puneeta Sharma. “Enoxaparin vs unfractionated heparin in acute coronary syndrome.” JAMA, vol. 292, no. 16, Oct. 2004, p. 1952. Pubmed, doi:10.1001/jama.292.16.1952-b.
Kanna B, Sharma P. Enoxaparin vs unfractionated heparin in acute coronary syndrome. JAMA. 2004 Oct 27;292(16):1952.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
October 27, 2004
Volume
292
Issue
16
Start / End Page
1952
Location
United States
Related Subject Headings
- Myocardial Infarction
- Humans
- Heparin
- General & Internal Medicine
- Fibrinolytic Agents
- Enoxaparin
- Angina Pectoris
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences